Equities

Kusurinomadoguchi Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
5592:TYO

Kusurinomadoguchi Inc

Actions
Health CareHealth Care Providers
  • Price (JPY)2,505.00
  • Today's Change-75.00 / -2.91%
  • Shares traded91.40k
  • 1 Year change+35.41%
  • Beta--
Data delayed at least 15 minutes, as of Mar 04 2026 06:23 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Kusurinomadoguchi Inc is a Japan-based company mainly engaged in the development and marketing of solutions primarily for pharmacies and healthcare. The media business operates EPARK Kusuri no Madoguchi, a search site and application for pharmacies such as dispensing pharmacies and drugstores, and EPARK Oyaku Techo, an electronic medication registry application. The Minnano Oyakubako business operates the Minnano Kyodo Shupply Service, which negotiates purchase prices of pharmaceuticals with pharmaceutical wholesalers on behalf of pharmacies and medical institutions, the e-Order System, which functions as an inventory management system and automatic ordering system for pharmaceuticals at pharmacies and medical institutions, and the Minnano Oyakubako application, which is a pharmaceuticals trading application. The core system business sells office processing systems and information systems required by medical institutions, pharmacies, and nursing care facilities.

  • Revenue in JPY (TTM)11.71bn
  • Net income in JPY2.59bn
  • Incorporated2004
  • Employees484.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
5592:TYO since
announced
Transaction
value
Medi Web Co LtdDeal completed05 Dec 202505 Dec 2025Deal completed-2.98%4.01m
Data delayed at least 15 minutes, as of Mar 04 2026 06:23 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Daiken Medical Co Ltd10.17bn981.12m15.28bn180.0014.051.7912.441.5034.1534.15353.89267.890.90354.563.6456,482,360.008.727.8611.8311.2538.7941.239.659.511.89183.100.193969.412.073.1511.035.01-0.18892.83
Seed Co Ltd33.57bn1.17bn16.53bn985.0014.090.88953.720.492338.7638.761,109.07613.830.642.357.4334,078,080.002.222.313.583.9445.1242.203.473.300.59286.620.575736.012.580.8892-44.3833.9912.644.56
Hoshi Iryo-Sanki Co Ltd15.45bn1.45bn17.78bn500.0011.220.841610.791.15463.58463.584,949.106,178.920.626224.075.8130,904,100.005.886.007.197.6149.7248.989.399.193.09--0.0015.312.196.784.2114.77-18.276.96
Japan Medical Dynamic Marketing Inc24.58bn-1.05bn18.22bn538.00--0.721733.730.741-40.02-40.02933.26953.320.72020.63684.3445,695,190.00-3.134.27-3.804.9459.9365.20-4.355.781.2812.480.180228.508.356.79-136.31---1.378.45
Medius Holdings Co Ltd295.20bn1.36bn18.39bn2.61k13.590.9075.110.062360.8660.8613,250.33911.802.3918.174.56112,928,700.001.101.654.356.0311.8212.070.45960.64920.924313.810.587328.5711.126.5322.307.6516.287.39
Techno Medica Co Ltd10.70bn1.04bn23.40bn244.0017.831.2920.602.19149.78149.781,542.982,077.510.64062.173.6943,841,880.006.226.587.167.7947.6849.669.7112.305.99--0.0040.22-3.680.1936-25.480.0825-40.566.77
Findex Inc6.11bn1.26bn24.80bn311.0018.654.1815.644.0649.9849.98243.37222.910.90579.853.67--18.9517.7021.9320.5865.2260.5820.9218.243.46----35.494.608.828.1423.902.5722.42
Kusurinomadoguchi Inc11.71bn2.59bn29.79bn484.0011.482.977.262.54228.38228.381,033.34882.360.6939--3.1924,186,230.0015.71--26.98--56.02--22.65------0.158--28.41--133.66------
Japan Tissue Engineering Co., Ltd.2.26bn-461.45m31.19bn204.00--5.92--13.81-11.36-11.3655.62129.740.36614.015.6311,071,850.00-7.48-4.87-8.33-5.5159.6259.41-20.43-15.896.59--0.00---2.341.23-278.32--0.5717--
Mizuho Medy Co Ltd11.26bn3.43bn36.54bn187.0010.671.969.903.25179.80179.80591.12980.860.52251.552.09--15.9027.7417.9633.0669.4474.5130.4336.696.46----37.29-1.4821.77-9.2262.0723.8782.06
Rion Co Ltd27.94bn2.98bn37.85bn1.01k12.681.148.691.35241.73241.732,267.252,682.200.71751.673.8927,692,170.007.656.578.727.6249.5350.1110.669.273.55--0.0028.398.365.377.829.9520.048.61
Nippon Care Supply Co., Ltd.34.10bn2.17bn39.60bn1.45k17.502.114.241.16139.36139.362,194.671,155.761.26101.8030.3523,453,350.008.007.3711.529.8036.4536.776.356.340.7615--0.091359.8011.9410.8813.573.7013.338.76
Data as of Mar 04 2026. Currency figures normalised to Kusurinomadoguchi Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

4.65%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 15 Aug 2024301.30k2.65%
Amova Asset Management Co., Ltd.as of 29 Sep 2025105.00k0.93%
Chibagin Asset Management Co. Ltd.as of 30 May 202459.10k0.52%
GW&K Investment Management LLCas of 30 Jan 202632.50k0.29%
Sumitomo Mitsui DS Asset Management Co., Ltd.as of 03 Feb 202515.60k0.14%
Simplex Asset Management Co., Ltd.as of 05 Feb 20267.40k0.07%
JPMorgan Asset Management (Japan) Ltd.as of 10 Sep 20255.20k0.05%
Mitsubishi UFJ Asset Management Co., Ltd.as of 26 Feb 20241.50k0.01%
More ▼
Data from 22 Jul 2025 - 19 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.